CA2047482A1 - Solid pharmaceutical composition - Google Patents

Solid pharmaceutical composition

Info

Publication number
CA2047482A1
CA2047482A1 CA002047482A CA2047482A CA2047482A1 CA 2047482 A1 CA2047482 A1 CA 2047482A1 CA 002047482 A CA002047482 A CA 002047482A CA 2047482 A CA2047482 A CA 2047482A CA 2047482 A1 CA2047482 A1 CA 2047482A1
Authority
CA
Canada
Prior art keywords
mass
chlorophyll
process according
nifedipine
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002047482A
Other languages
English (en)
French (fr)
Inventor
Margit Nagy Nee Kricsfalussy
Rita Balazs
Judit Marcisz
Katalin Wagner Nee Nagy
Eva Judith Tajthy Nee Juhasz
Attila Mandi
Margit Csorgo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Gyógyszergyár Zrt
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2047482A1 publication Critical patent/CA2047482A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002047482A 1990-07-20 1991-07-19 Solid pharmaceutical composition Abandoned CA2047482A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4564/90 1990-07-20
HU904564A HUT59592A (en) 1990-07-20 1990-07-20 Process for the preparation of solid medical products

Publications (1)

Publication Number Publication Date
CA2047482A1 true CA2047482A1 (en) 1992-01-21

Family

ID=10968329

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002047482A Abandoned CA2047482A1 (en) 1990-07-20 1991-07-19 Solid pharmaceutical composition

Country Status (22)

Country Link
JP (1) JPH04253924A (enExample)
KR (1) KR920002162A (enExample)
BE (1) BE1006829A3 (enExample)
CA (1) CA2047482A1 (enExample)
CH (1) CH681960A5 (enExample)
CY (1) CY1840A (enExample)
CZ (1) CZ280064B6 (enExample)
DE (1) DE4124081A1 (enExample)
DK (1) DK137591A (enExample)
ES (1) ES2039177B1 (enExample)
FI (1) FI913493A7 (enExample)
FR (1) FR2664814B1 (enExample)
GB (1) GB2246072B (enExample)
GR (1) GR1002175B (enExample)
HU (1) HUT59592A (enExample)
IL (1) IL98894A0 (enExample)
IT (1) IT1250681B (enExample)
NL (1) NL9101268A (enExample)
SE (1) SE9102160L (enExample)
TW (1) TW203012B (enExample)
YU (1) YU47573B (enExample)
ZA (1) ZA915677B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072791B2 (en) 2008-09-30 2015-07-07 Denki Kagaku Kogyo Kabushiki Kaisha Photostabilized pharmaceutical compositions
US10543202B2 (en) 2017-05-30 2020-01-28 University Of Sasktachewan Topical nifedipine formulations and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411115D0 (en) * 1994-06-03 1994-07-27 Secr Defence Stabilisation of photosensitive material
WO1996033701A1 (en) * 1995-04-24 1996-10-31 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
JP3549522B1 (ja) * 2003-10-24 2004-08-04 日清ファルマ株式会社 コエンザイムｑ１０含有カプセル剤
KR200489660Y1 (ko) * 2018-02-09 2019-07-19 김순희 퍼팅연습기

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55127448A (en) * 1979-03-23 1980-10-02 Chugai Pharmaceut Co Ltd Gelatin coating
JPS6043046B2 (ja) * 1979-04-24 1985-09-26 パ−ク・デ−ビス・エンド・コンパニ− ゼラチンカプセル
JPS55161863A (en) * 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
EP0143857B1 (de) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Coronartherapeutikum in Form von Weichgelatine-Kapseln
JPS61225109A (ja) * 1985-03-29 1986-10-06 Shiseido Co Ltd カラメル含有組成物
DE3526546A1 (de) * 1985-07-25 1987-01-29 Scherer Gmbh R P Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
JPS63215641A (ja) * 1987-03-05 1988-09-08 Toyo Jozo Co Ltd ゼラチン皮膜組成物
JPH01218573A (ja) * 1988-02-25 1989-08-31 Yoshio Tanaka ドナリエラ藻体含有固形状食品の製造法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072791B2 (en) 2008-09-30 2015-07-07 Denki Kagaku Kogyo Kabushiki Kaisha Photostabilized pharmaceutical compositions
US10543202B2 (en) 2017-05-30 2020-01-28 University Of Sasktachewan Topical nifedipine formulations and uses thereof

Also Published As

Publication number Publication date
GB2246072A (en) 1992-01-22
SE9102160D0 (sv) 1991-07-10
ITMI912002A0 (it) 1991-07-19
YU47573B (sh) 1995-10-03
NL9101268A (nl) 1992-02-17
GR1002175B (en) 1996-03-07
HU904564D0 (en) 1990-12-28
DK137591A (da) 1992-01-21
IT1250681B (it) 1995-04-21
HUT59592A (en) 1992-06-29
ZA915677B (en) 1993-03-31
GR910100319A (el) 1992-08-26
FI913493A0 (fi) 1991-07-19
KR920002162A (ko) 1992-02-28
CZ280064B6 (cs) 1995-10-18
GB9115693D0 (en) 1991-09-04
IL98894A0 (en) 1992-07-15
YU127191A (sh) 1994-05-10
JPH04253924A (ja) 1992-09-09
CH681960A5 (enExample) 1993-06-30
CS222291A3 (en) 1992-02-19
BE1006829A3 (fr) 1995-01-03
FI913493L (fi) 1992-01-21
SE9102160L (sv) 1992-01-21
TW203012B (enExample) 1993-04-01
CY1840A (en) 1996-03-08
DE4124081A1 (de) 1992-01-23
GB2246072B (en) 1994-06-15
ES2039177A1 (es) 1993-09-01
ES2039177B1 (es) 1994-03-16
FR2664814B1 (fr) 1995-05-24
DK137591D0 (da) 1991-07-19
FI913493A7 (fi) 1992-01-21
ITMI912002A1 (it) 1993-01-19
FR2664814A1 (fr) 1992-01-24

Similar Documents

Publication Publication Date Title
DE69824277T2 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
CA1209039A (en) Masticatory gelatin capsules
US4532126A (en) Masticatory soft elastic gelatin capsules and method for the manufacture thereof
HU198837B (en) Process for producing hard gelatine capsule containing chewable composition
HU210461A9 (en) Pharmaceutical composition for prolongated release of a dihydropyridine and a beta-adrenoreceptor antagonist and process for producing the composition
WO2002011701A1 (en) A controlled release pharmaceutical composition
CZ20013058A3 (cs) Farmaceutický prostředek pro orální podávání
CA2212309C (en) Extended-release solid oral dosage forms of drugs having low solubility in water
JP4750270B2 (ja) アルテミニシニン及び／又はアルテミシニン誘導体を含有する製薬学的活性組成物
HUP0101043A2 (hu) [R-(Z)]-alfa-(Metoxi-imino)-alfa-(1-aza-biciklo[2.2.2]okt-3-il)-acetonitril-monohidroklorid szabályozott kibocsátású orális dózisforma és eljárás előállítására
GB2246072A (en) Pharmaceutical compositions stabilised against light
US4313930A (en) Stable valepotriate compounds and process for their preparation
JPS63310827A (ja) ニコチン酸誘導体を主剤とする徐放性製剤
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
SK7342000A3 (en) Formulations comprising dissolved paroxetine
HU227472B1 (en) Slow-release pharmaceutical formulations containing mizolastin
WO2005023236A1 (en) Phenylephrine tannate, pyrilamine tannate, and dextromethorphan tannate salts in pharmaceutical compositions
RU2053764C1 (ru) Мягкая желатиновая капсула и способ ее получения
DD217712A5 (de) Verfahren zur herstellung eines pharmazeutischen praeparates
EP0326103B1 (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
AU2018419112B2 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
JP2008515839A (ja) レルカニジピンカプセル
CH700941B1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
CA3094550C (en) Instant release pharmaceutical preparations of vicagrel and preparation methods therefor
DE3413955C2 (enExample)

Legal Events

Date Code Title Description
FZDE Discontinued